vs

Side-by-side financial comparison of Origin Bancorp, Inc. (OBK) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $104.0M, roughly 1.4× Origin Bancorp, Inc.). Origin Bancorp, Inc. runs the higher net margin — 26.6% vs -21.1%, a 47.7% gap on every dollar of revenue. Over the past eight quarters, Origin Bancorp, Inc.'s revenue compounded faster (3.9% CAGR vs -7.5%).

Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

OBK vs OPK — Head-to-Head

Bigger by revenue
OPK
OPK
1.4× larger
OPK
$148.5M
$104.0M
OBK
Higher net margin
OBK
OBK
47.7% more per $
OBK
26.6%
-21.1%
OPK
Faster 2-yr revenue CAGR
OBK
OBK
Annualised
OBK
3.9%
-7.5%
OPK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
OBK
OBK
OPK
OPK
Revenue
$104.0M
$148.5M
Net Profit
$27.7M
$-31.3M
Gross Margin
43.1%
Operating Margin
-25.8%
Net Margin
26.6%
-21.1%
Revenue YoY
-19.2%
Net Profit YoY
-322.8%
EPS (diluted)
$0.89
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OBK
OBK
OPK
OPK
Q1 26
$104.0M
Q4 25
$103.4M
$148.5M
Q3 25
$109.8M
$151.7M
Q2 25
$83.5M
$156.8M
Q1 25
$94.1M
$150.0M
Q4 24
$78.3M
$183.6M
Q3 24
$90.8M
$173.6M
Q2 24
$96.4M
$182.2M
Net Profit
OBK
OBK
OPK
OPK
Q1 26
$27.7M
Q4 25
$29.5M
$-31.3M
Q3 25
$8.6M
$21.6M
Q2 25
$14.6M
$-148.4M
Q1 25
$22.4M
$-67.6M
Q4 24
$14.3M
$14.0M
Q3 24
$18.6M
$24.9M
Q2 24
$21.0M
$-10.3M
Gross Margin
OBK
OBK
OPK
OPK
Q1 26
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Operating Margin
OBK
OBK
OPK
OPK
Q1 26
Q4 25
36.2%
-25.8%
Q3 25
10.0%
31.7%
Q2 25
22.3%
-38.3%
Q1 25
30.4%
-44.8%
Q4 24
23.0%
-18.0%
Q3 24
26.1%
8.2%
Q2 24
27.7%
-33.9%
Net Margin
OBK
OBK
OPK
OPK
Q1 26
26.6%
Q4 25
28.5%
-21.1%
Q3 25
7.9%
14.3%
Q2 25
17.5%
-94.7%
Q1 25
23.8%
-45.1%
Q4 24
18.2%
7.6%
Q3 24
20.5%
14.3%
Q2 24
21.8%
-5.7%
EPS (diluted)
OBK
OBK
OPK
OPK
Q1 26
$0.89
Q4 25
$0.95
$-0.04
Q3 25
$0.27
$0.03
Q2 25
$0.47
$-0.19
Q1 25
$0.71
$-0.10
Q4 24
$0.45
$0.02
Q3 24
$0.60
$0.03
Q2 24
$0.67
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OBK
OBK
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$1.3B
Total Assets
$10.2B
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OBK
OBK
OPK
OPK
Q1 26
Q4 25
$424.2M
$364.4M
Q3 25
$626.9M
$412.0M
Q2 25
$334.1M
$267.3M
Q1 25
$486.2M
$428.8M
Q4 24
$470.2M
$426.6M
Q3 24
$321.2M
$400.1M
Q2 24
$288.1M
$40.6M
Total Debt
OBK
OBK
OPK
OPK
Q1 26
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Stockholders' Equity
OBK
OBK
OPK
OPK
Q1 26
$1.3B
Q4 25
$1.2B
$1.3B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.2B
$1.3B
Q4 24
$1.1B
$1.4B
Q3 24
$1.1B
$1.4B
Q2 24
$1.1B
$1.4B
Total Assets
OBK
OBK
OPK
OPK
Q1 26
$10.2B
Q4 25
$9.7B
$1.9B
Q3 25
$9.8B
$2.0B
Q2 25
$9.7B
$2.0B
Q1 25
$9.8B
$2.1B
Q4 24
$9.7B
$2.2B
Q3 24
$10.0B
$2.3B
Q2 24
$9.9B
$2.0B
Debt / Equity
OBK
OBK
OPK
OPK
Q1 26
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OBK
OBK
OPK
OPK
Operating Cash FlowLast quarter
$-25.9M
Free Cash FlowOCF − Capex
$-28.6M
FCF MarginFCF / Revenue
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OBK
OBK
OPK
OPK
Q1 26
Q4 25
$158.9M
$-25.9M
Q3 25
$59.3M
$-34.6M
Q2 25
$20.6M
$-83.4M
Q1 25
$35.6M
$-34.6M
Q4 24
$108.5M
$-44.4M
Q3 24
$39.6M
$-77.1M
Q2 24
$11.9M
$-26.4M
Free Cash Flow
OBK
OBK
OPK
OPK
Q1 26
Q4 25
$151.1M
$-28.6M
Q3 25
$56.8M
$-37.8M
Q2 25
$19.6M
$-86.7M
Q1 25
$34.8M
$-37.7M
Q4 24
$86.4M
$-49.8M
Q3 24
$32.2M
$-85.0M
Q2 24
$6.5M
$-33.7M
FCF Margin
OBK
OBK
OPK
OPK
Q1 26
Q4 25
146.0%
-19.3%
Q3 25
51.7%
-24.9%
Q2 25
23.5%
-55.3%
Q1 25
37.0%
-25.2%
Q4 24
110.3%
-27.1%
Q3 24
35.5%
-49.0%
Q2 24
6.8%
-18.5%
Capex Intensity
OBK
OBK
OPK
OPK
Q1 26
Q4 25
7.6%
1.8%
Q3 25
2.3%
2.1%
Q2 25
1.2%
2.1%
Q1 25
0.8%
2.1%
Q4 24
28.1%
2.9%
Q3 24
8.1%
4.6%
Q2 24
5.6%
4.0%
Cash Conversion
OBK
OBK
OPK
OPK
Q1 26
Q4 25
5.38×
Q3 25
6.88×
-1.60×
Q2 25
1.41×
Q1 25
1.59×
Q4 24
7.60×
-3.17×
Q3 24
2.13×
-3.10×
Q2 24
0.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OBK
OBK

Net Interest Income$87.2M84%
Noninterest Income$16.8M16%

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons